eFinder

eFinder

Home › Article

GLP-1 drugs may reduce the risk of cancer progressing, study suggests

Nbcwashington · · 783 words · By Kaitlin Sullivan; NBC News
open_in_new Read the original article: https://www.nbcwashington.com/news/national-international/glp-1-drugs-may-reduce…

fact_checkFact-Check Results

10 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

info Single Source 7
help Insufficient Evidence 2
check_circle Corroborated 1
check_circle
“approvals have been expanded to reduce risk of heart disease (Wegovy), to prevent worsening kidney disease (Ozempic) and to treat obstructive sleep apnea (Zepbound)”
CORROBORATED
Web search results confirm Wegovy is approved to reduce heart disease risk and Ozempic is used to reduce the risk of kidney disease worsening. While Zepbound's specific sleep apnea approval is not explicitly detailed in the snippets, the other two are confirmed by separate search results.
travel_explore
web search NEUTRAL — to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease. Ozempic 4 …
https://www.drugs.com/medical-answers/mounjaro-wegovy-ozempi…
travel_explore
web search NEUTRAL — GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting.
https://www.nbcnews.com/health/cancer/glp-1-drugs-may-reduce…
travel_explore
web search NEUTRAL — Wegovy is also approved to reduce excess weight and maintain weight reduction long term in certain adults with obesity or overweight and certain children with obesity, for use in addition to a reduced…
https://www.fda.gov/news-events/press-announcements/fda-appr…
info
“Dr. Mark Orland, an internal medicine physician at Cleveland Clinic, led the study.”
SINGLE SOURCE
The provided web search results for this claim are completely irrelevant, discussing cardiology and orthopedic clinics in Bakersfield rather than Dr. Mark Orland or the specific study.
travel_explore
web search NEUTRAL — Experience personalized heart health services at Aggarwal Cardiology Clinic. Expert care, advanced technology, and a focus on your well-being await you.
https://aggarwalclinic.com/
travel_explore
web search NEUTRAL — Schedule an appointment today at SCOI’s Bakersfield orthopedic clinic, providing general orthopedics, physical therapy/rehab, and advanced diagnostics.
https://scoi.com/locations/bakersfield-truxtun/
travel_explore
web search NEUTRAL — Cindy Cortez is a board-certified Family Nurse Practitioner at the California Neurology Institute. With emergency and critical care experience, she specializes in neurological conditions.
https://caneuroinst.com/
info
“Orland and his colleagues looked at patient records from the TriNetX Global Health Research Network database, identifying more than 10,000 people who had been diagnosed with one of seven types of cancer —breast, colorectal, kidney, liver, lung, pancreatic and prostate cancers.”
SINGLE SOURCE
The provided web search results are generic advertisements for study tools and online courses and do not mention the TriNetX database or the specific cancer study.
travel_explore
web search NEUTRAL — Take online courses on Study.com that are fun and engaging. Pass exams to earn real college credit. Research schools and degrees to further your education.
https://study.com/
travel_explore
web search NEUTRAL — Master any subject with Studley AI. Trusted by more than 2,000,000 top students. Create beautiful and interactive notes, flashcards, quizzes and podcasts from any content. Study smarter, not harder.
https://www.studley.ai/
travel_explore
web search NEUTRAL — StudyX helps students study with AI throughout the entire learning journey. Students can use it to get homework help, turn lectures and study materials into notes, generate flashcards and quizzes for …
https://studyx.ai/
info
“All the patients had stage 1, 2 or 3 cancer and started taking a GLP-1 drug after their cancer diagnosis.”
SINGLE SOURCE
One source mentions that GLP-1 drugs may be linked to lower cancer progression research presented at ASCO, but the specific details regarding stage 1, 2, or 3 cancer and timing of drug initiation are not corroborated by other independent sources in the provided evidence.
travel_explore
web search NEUTRAL — GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting.
https://www.nbcnews.com/health/cancer/glp-1-drugs-may-reduce…
travel_explore
web search NEUTRAL — Typically someone taking these drugs will begin to lose weight within the first few weeks. Although the drugs are only approved for weight loss in people with obesity, there is a rapidly growing priva…
https://www.bbc.com/future/article/20260401-why-weight-loss-…
travel_explore
web search NEUTRAL — Across all studies, participants taking obesity medications lost an average of 10.9% of their body weight compared with placebo. This was accompanied by an average reduction of 5.2 mmHg in systolic bl…
https://www.medicalnewstoday.com/articles/weight-loss-medica…
info
“people in the control group started taking a different Type 2 diabetes drug called a DPP-4 inhibitor after their cancer diagnosis.”
SINGLE SOURCE
The claim is explicitly stated in one web search result regarding the ASCO presentation, but no other independent source corroborates this specific study design.
travel_explore
web search NEUTRAL — The difference was that people in the control group started taking a different Type 2 diabetes drug called a DPP-4 inhibitor after their cancer diagnosis.
https://www.nbcnews.com/health/cancer/glp-1-drugs-may-reduce…
travel_explore
web search NEUTRAL — Risks and burdens of incident diabetes in long COVID: a cohort study.
https://www.thelancet.com/journals/landia/article/PIIS2213-8…
travel_explore
web search NEUTRAL — Introduction: Dipeptidyl peptidase 4 inhibitors (DPP-4 inhibitors) are incretin-based oral antidiabetic drugs.Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta…
https://www.frontiersin.org/journals/public-health/articles/…
info
“In every type of cancer except kidney cancer, people who started GLP-1 medications were less likely to have their tumors metastasize, or spread.”
SINGLE SOURCE
While one source mentions the general link between GLP-1s and reduced cancer progression, the specific detail about 'every type except kidney cancer' is not corroborated by the other provided sources.
travel_explore
web search NEUTRAL — GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting.
https://www.nbcnews.com/health/cancer/glp-1-drugs-may-reduce…
travel_explore
web search NEUTRAL — “For example, the study showed that GLP-1RAs were associated with a hazard ratio of 0.35 for gallbladder cancer, 0.41 for pancreatic cancer, and 0.54 for colorectal cancer when compared to insulin, su…
https://www.ibmnc.org/some-diabetes-drugs-like-ozempic-may-l…
travel_explore
web search NEUTRAL — Most cancer-associated deaths occur due to metastasis, yet our understanding of metastasis as an evolving, heterogeneous, systemic disease and of how to effectively treat it is still emerging.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10511214/
info
“only four of the seven cancers — non-small cell lung cancer, breast cancer, colorectal cancer and liver cancer — had a statistically significant reduction in people whose cancer advanced.”
SINGLE SOURCE
The specific list of four cancers (non-small cell lung, breast, colorectal, and liver) showing statistically significant reduction is mentioned in one source, but not corroborated by others.
travel_explore
web search NEUTRAL — Cancer is a group of diseases involving uncontrolled cell growth typically resulting in tumors with the potential to invade or spread to other parts of the body.[2][7] These malignant tumors contrast …
https://en.wikipedia.org/wiki/Cancer
travel_explore
web search NEUTRAL — However, only four of the seven cancers — non-small cell lung cancer, breast cancer, colorectal cancer and liver cancer — had a statistically significant reduction in people whose cancer advanced.
https://www.nbcnews.com/health/cancer/glp-1-drugs-may-reduce…
travel_explore
web search NEUTRAL — Advanced lung cancer though may be treated with a single chemo drug especially in people who might not tolerate combination chemotherapy well, such as those in poor overall health or who are elderly.
https://www.cancer.org/cancer/types/lung-cancer/treating-non…
info
“People with lung cancer who were on GLP-1s were 50% less likely to progress to stage 4 than those taking a DPP-4 inhibitor.”
SINGLE SOURCE
The general topic of the study is mentioned in one source, but the specific '50% less likely' figure for lung cancer is not corroborated by any other independent source in the provided evidence.
travel_explore
web search NEUTRAL — To overcome this, GLP-1 receptor agonists and DPP-4 inhibitors have been developed to increase GLP-1 activity. As opposed to common treatment agents such as insulin and sulphonylureas, GLP-1-based tre…
https://en.wikipedia.org/wiki/Glucagon-like_peptide-1
travel_explore
web search NEUTRAL — GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting.
https://www.nbcnews.com/health/cancer/glp-1-drugs-may-reduce…
travel_explore
web search NEUTRAL — Wow I did not expect for this go go viral! If you are a cancer patient, I encourage you to join our Community platform at https://skool.com/ketoforcancer - a...
https://www.youtube.com/watch?v=GbyuAr4GWlk
help
“For breast cancer, people taking a GLP-1 were 43% less likely to progress.”
INSUFFICIENT EVIDENCE
No evidence was provided for this claim.
help
“Among those taking GLP-1 receptor agonists, those whose tumors had more GLP-1 receptors were less likely to have their cancer metastasize”
INSUFFICIENT EVIDENCE
No evidence was provided for this claim.
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.